• SENSEX 80,567.71
    409.83 (+0.51%)
  • BANKNIFTY 54,067.55
    406.55 (+0.76%)
  • Ola Electric
    70.25 123.90(%)
  • N S D L
    1,236.20 880.00(%)
  • Aditya Vision
    447.00 328.25(%)
  • Vimta Labs
    829.00 787.20(%)
  • One Mobikwik
    300.00 698.30(%)
  • Tata Steel
    168.00 170.20(%)
  • Netweb Technol.
    2,564.75 3,060.00(%)
  • Apollo Micro Sys
    306.60 298.70(%)
  • Aurobindo Pharma
    1,041.00 1,592.55(%)
  • Jai Corp
    170.15 406.00(%)
  • Moschip Tech.
    196.45 279.00(%)
  • Godfrey Phillips
    10,420.00 11,462.00(%)
  • Yes Bank
    20.38 24.40(%)
  • M & M
    3,292.60 3,430.10(%)
  • NTPC
    333.45 292.70(%)
  • TBO Tek
    1,609.20 2,000.00(%)
  • AU Small Finance
    716.05 840.95(%)
  • Larsen & Toubro
    3,606.35 3,963.00(%)
  • TCS
    3,087.75 2,992.05(%)
  • Bharat Electron
    381.05 435.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Colinz Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5989.0
  • ISIN : INE923C01011
41.24 -2 (-4.93%)
  • As on 03 Sep 2025 (EOD)

  • Today’s Low

    41.22

  • Today’s High

    44.99

  • Open

    44.99

  • Perv Close

    43.38

  • 52W Low

    37.87

  • 52W High

    88.70

Key Indicators

  • P/E(TTM)

    41.31

  • Mar.Cap (₹Cr.)

    19.83

  • Div & Yield %

    0.00

  • Book Value(₹)

    25.22

  • Debt-Equity Ratio

    -4.93

  • AGM Date

    03-Sep-2025

  • EPS

    1.05

  • P/E Ratio

    41.31

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    19.83

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.57

  • BV (₹)

    25.20

  • Sales( ₹ in Cr.)

    6.53

  • NP (in Cr.)

    0.50

  • NP Var(%)

    2.0

  • Div%

    0.0

  • CPS (₹)

    1.40

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    19.83

  • 52 Week High

    88.70

  • 52 Week Low

    37.87

  • Price BSE

    43.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    19.83

  • P/C Ratio

    31.20

  • P/E Ratio

    39.50

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 6.53 7.03 7.15 6.97 6.16 7.60
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.07
Net Sales 6.53 7.03 7.15 6.97 6.16 7.53
Other Income 0.30 0.28 0.17 0.17 0.19 0.13
Stock Adjustments -0.08 -0.08 0.03 -0.33 -0.47 -0.12
Total Income 6.75 7.23 7.35 6.81 5.88 7.54
EXPENDITURE :            
Raw Materials 2.01 2.23 2.33 1.97 1.72 2.62
Power and Fuel Cost 0.12 0.11 0.11 0.08 0.08 0.09
Employee Cost 2.67 2.79 2.90 2.77 2.39 3.25
Other Manufacturing Expenses 0.10 0.23 0.14 0.14 0.13 0.06
Selling and Administration Expenses 1.05 1.04 1.08 1.03 0.96 1.08
Miscellaneous Expenses 0.01 0.00 0.03 0.06 0.09 0.01
Employee Benefit Expenses 2.67 2.79 2.90 2.77 2.39 3.25
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5.95 6.40 6.58 6.06 5.36 7.11
Operating Profit 0.79 0.82 0.78 0.76 0.53 0.44
Interest 0.04 0.04 0.05 0.08 0.09 0.07
Gross Profit 0.75 0.78 0.73 0.68 0.44 0.37
Depreciation 0.13 0.13 0.13 0.20 0.19 0.19
Profit Before Tax 0.62 0.65 0.60 0.48 0.25 0.18
Current Tax 0.18 0.18 0.16 0.15 0.08 0.07
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.05 -0.01 -0.02 -0.01 -0.04 -0.02
Reported Net Profit 0.50 0.49 0.46 0.34 0.21 0.13
Extraordinary Items 0.00 0.00 -0.02 0.00 0.00 0.00
Adjusted Net Profit 0.50 0.49 0.48 0.34 0.21 0.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 2.96 2.47 2.01 1.67 1.47 1.34
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 3.45 2.96 2.47 2.01 1.67 1.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.97 1.93 1.82 0.96 0.59 0.37
Earnings Per Share(Adj)-Unit Curr 1.97 1.93 1.82 0.96 0.59 0.37
Book Value 37.61 35.52 32.31 21.69 20.57 19.29
Book Value(Adj)-Unit Curr 37.61 35.52 32.31 21.69 20.57 19.29

Shareholding Pattern

  • Promoter Group

    66.00%

  • Public Share Holding

    34.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,662,659 66.00 1,257,159 156
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,662,659 66.00 1,257,159 156
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 25,158 1.00 19,858 17
Clearing Members 54 0.00 54 1
Directors of their Relatives 0 0.00 0 0
Employees 3,900 0.15 500 18
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 14,954 0.59 4,254 31
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 30,364 1.21 30,364 35
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 64,440 2.56 64,440 2
Individuals holding nominal share capital up to Rs. 1 lakh 717,571 28.49 469,486 2,978
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 856,441 34.00 588,956 3,082
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,519,100 100.00 1,846,115 3,238

Company Background

Colinz Laboratories LtdPharmaceuticals - Indian - Formulations

  • Colinz Laboratories Ltd
  • BSE Code : 5989.0
  • ISIN : INE923C01011

  • Incorporation Year

    1986

  • Registered Office

    A-101 Pratik Industrial Estate
    Mulund Goregaon Link Road, Mumbai,
    Maharashtra-400078

  • Telephone

    91-022-25668002/8003

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    L S Mani

  • Auditor

    Vora & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Colinz Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Colinz Labs 43.38 6.83 6.53 41.31 6.72
Abbott India 32,356.30 6,684.73 6,409.15 47.34 44.95
Astrazeneca Phar 8,937.85 1,756.92 1,716.29 121.87 32.94
P & G Health Ltd 6,321.25 944.52 934.17 34.91 40.23
Glaxosmi. Pharma 2,749.15 3,866.05 3,723.49 49.44 58.72
Cipla 1,568.95 20,029.57 19,044.85 23.45 21.40
Amrutanjan Healt 729.20 469.50 451.82 38.66 21.89
Guj. Themis Bio. 376.95 152.47 150.80 92.16 27.21
Fermenta Biotec. 328.45 442.21 430.53 10.90 17.61
Bliss GVS Pharma 159.40 703.42 667.20 23.83 9.16
Ambalal Sarabhai 32.71 19.33 4.04 17.13 2.10